Correlation Between CHRYSALIS INVESTMENTS and ALZECURE PHARMA

Can any of the company-specific risk be diversified away by investing in both CHRYSALIS INVESTMENTS and ALZECURE PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHRYSALIS INVESTMENTS and ALZECURE PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CHRYSALIS INVESTMENTS LTD and ALZECURE PHARMA AB, you can compare the effects of market volatilities on CHRYSALIS INVESTMENTS and ALZECURE PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHRYSALIS INVESTMENTS with a short position of ALZECURE PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHRYSALIS INVESTMENTS and ALZECURE PHARMA.

Diversification Opportunities for CHRYSALIS INVESTMENTS and ALZECURE PHARMA

0.58

Correlation Coefficient

CHRYSALIS INVESTMENTS  ALZECURE PHARMA

Very weak diversification

The 3 months correlation between CHRYSALIS and ALZECURE is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding CHRYSALIS INVESTMENTS LTD and ALZECURE PHARMA AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALZECURE PHARMA AB and CHRYSALIS INVESTMENTS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHRYSALIS INVESTMENTS LTD are associated (or correlated) with ALZECURE PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALZECURE PHARMA AB has no effect on the direction of CHRYSALIS INVESTMENTS i.e., CHRYSALIS INVESTMENTS and ALZECURE PHARMA go up and down completely randomly.

Pair Corralation between CHRYSALIS INVESTMENTS and ALZECURE PHARMA

Assuming the 90 days horizon CHRYSALIS INVESTMENTS is expected to generate 7.07 times less return on investment than ALZECURE PHARMA. But when comparing it to its historical volatility, CHRYSALIS INVESTMENTS LTD is 12.62 times less risky than ALZECURE PHARMA. It trades about 0.22 of its potential returns per unit of risk. ALZECURE PHARMA AB is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  19.00  in ALZECURE PHARMA AB on April 22, 2025 and sell it today you would earn a total of  11.00  from holding ALZECURE PHARMA AB or generate 57.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CHRYSALIS INVESTMENTS LTD  vs.  ALZECURE PHARMA AB

CHRYSALIS INVESTMENTS LTD

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in CHRYSALIS INVESTMENTS LTD are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, CHRYSALIS INVESTMENTS reported solid returns over the last few months and may actually be approaching a breakup point.

ALZECURE PHARMA AB

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ALZECURE PHARMA AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ALZECURE PHARMA reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CHRYSALIS INVESTMENTS and ALZECURE PHARMA

The main advantage of trading using opposite CHRYSALIS INVESTMENTS and ALZECURE PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHRYSALIS INVESTMENTS position performs unexpectedly, ALZECURE PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALZECURE PHARMA will offset losses from the drop in ALZECURE PHARMA's long position.

The idea behind CHRYSALIS INVESTMENTS LTD and ALZECURE PHARMA AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.